BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24065405)

  • 61. Thyroid function: optimizing molecular testing in thyroid nodule cytology.
    Pacini F
    Nat Rev Endocrinol; 2012 May; 8(7):390-1. PubMed ID: 22641002
    [No Abstract]   [Full Text] [Related]  

  • 62. Molecular diagnostics in cutaneous lymphomas.
    Möbs M; Cerroni L; Flaig MJ; Lenze D; Hummel M; Assaf C
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():25-35. PubMed ID: 23721639
    [No Abstract]   [Full Text] [Related]  

  • 63. A Practical Guide to the Role of Ancillary Techniques in the Diagnosis of Infectious Agents in Fine Needle Aspiration Samples.
    Glaser LJ; Montone KT
    Acta Cytol; 2020; 64(1-2):81-91. PubMed ID: 30889574
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular diagnosis of infectious diseases using cytological specimens.
    Canberk S; Longatto-Filho A; Schmitt F
    Diagn Cytopathol; 2016 Feb; 44(2):156-64. PubMed ID: 26620694
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The run for a million continues: is there still space for traditional techniques beyond molecular testing for indeterminate thyroid nodule cytology?
    Ferraz C
    Arch Endocrinol Metab; 2020 Aug; 64(4):329-330. PubMed ID: 32813761
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparative effectiveness in personalized medicine-clearly defining the intended use population.
    Hornberger JC
    Value Health; 2013 Jun; 16(4):696. PubMed ID: 23796304
    [No Abstract]   [Full Text] [Related]  

  • 67. Authors' response to "comparative effectiveness and personalized medicine" by Dr. J.C. Hornberger.
    Najafzadeh M; Marra CA; Lynd L; Wiseman S
    Value Health; 2013 Jun; 16(4):697. PubMed ID: 23796305
    [No Abstract]   [Full Text] [Related]  

  • 68. Molecular biomarkers in thyroid FNA samples.
    Melillo RM; Santoro M
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4370-3. PubMed ID: 23223485
    [No Abstract]   [Full Text] [Related]  

  • 69. Cancer: Indeterminate thyroid nodules--added testing, added value?
    Kwak JY; Kim EK
    Nat Rev Endocrinol; 2013 Jun; 9(6):321-3. PubMed ID: 23591368
    [No Abstract]   [Full Text] [Related]  

  • 70. Molecular testing of residual cytology samples: Rethink, reclaim, repurpose.
    Roy-Chowdhuri S
    Cancer Cytopathol; 2019 Feb; 127(1):15-17. PubMed ID: 30317690
    [No Abstract]   [Full Text] [Related]  

  • 71. Efficiency versus effectiveness: impact of molecular testing on healthcare costs and clinical outcome of patients with indeterminate thyroid nodules.
    Labourier E
    Med Oncol; 2016 Jul; 33(7):79. PubMed ID: 27307224
    [No Abstract]   [Full Text] [Related]  

  • 72. Preface. Molecular diagnostics in dermatology.
    Stadler R; Enk A
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():1. PubMed ID: 23721632
    [No Abstract]   [Full Text] [Related]  

  • 73. [Diagnostic principles for evaluation of retinal disorders. Part 1: functional analysis].
    Rüther K; Kellner S
    Klin Monbl Augenheilkd; 2013 Sep; 230(9):e20. PubMed ID: 24043579
    [No Abstract]   [Full Text] [Related]  

  • 74. Genetic tests and their evaluation: can we answer the key questions?
    Kroese M; Zimmern RL; Sanderson S
    Genet Med; 2004; 6(6):475-80. PubMed ID: 15545742
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Diagnostic vitrectomy in uveitis: possibilities of molecular biology].
    Becker MD; Bodaghi B; Holz FG; Harsch N; Hoang PL
    Ophthalmologe; 2003 Oct; 100(10):796-801. PubMed ID: 14618351
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Not Available].
    Bode-Lesniewska B
    Ther Umsch; 2017 Sep; 74(4):204-208. PubMed ID: 28950776
    [No Abstract]   [Full Text] [Related]  

  • 77. [Not Available].
    Menter T; Tzankov A; Dirnhofer S
    Ther Umsch; 2017 Sep; 74(4):197-203. PubMed ID: 28950777
    [No Abstract]   [Full Text] [Related]  

  • 78. [Molecular diagnosis for cardiovascular diseases].
    Schulze-Bahr E; Klaassen S; Abdul-Khaliq H; Schunkert H
    Dtsch Med Wochenschr; 2015 Oct; 140(20):1538. PubMed ID: 26445261
    [No Abstract]   [Full Text] [Related]  

  • 79. Evaluation of the Universal Master Mix (STAT-NAT DNA-Mix) for reliable molecular testing.
    Castiglioni E; Gramegna M; Moiana A; Zanussi M; Ferrari M
    Clin Chem Lab Med; 2013 Jun; 51(6):e133-6. PubMed ID: 23241611
    [No Abstract]   [Full Text] [Related]  

  • 80. From the lab to the clinic: integration of pharmacogenics into clinical development.
    Hoban CJ
    Pharmacogenomics; 2002 Jul; 3(4):429-36. PubMed ID: 12164766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.